Skip to main content

Peer Review reports

From: Preclinical evaluation and reverse phase protein Array-based profiling of PI3K and MEK inhibitors in endometrial carcinoma in vitro

Original Submission
19 Jul 2016 Submitted Original manuscript
15 Jun 2017 Author responded Author comments - Ozlem Aslan
3 Jan 2017 Reviewed Reviewer Report - Leslie Randall
9 Mar 2017 Reviewed Reviewer Report - J. Julie Kim
8 Feb 2017 Reviewed Reviewer Report - Jose M. Teixeira
Resubmission - Version 2
15 Jun 2017 Submitted Manuscript version 2
6 Oct 2017 Author responded Author comments - Ozlem Aslan
5 Jul 2017 Reviewed Reviewer Report - Leslie Randall
22 Jun 2017 Reviewed Reviewer Report - J. Julie Kim
Resubmission - Version 3
6 Oct 2017 Submitted Manuscript version 3
21 Nov 2017 Author responded Author comments - Ozlem Aslan
Resubmission - Version 4
21 Nov 2017 Submitted Manuscript version 4
4 Dec 2017 Author responded Author comments - Ozlem Aslan
Resubmission - Version 5
4 Dec 2017 Submitted Manuscript version 5
28 Dec 2017 Author responded Author comments - Ozlem Aslan
Resubmission - Version 6
28 Dec 2017 Submitted Manuscript version 6
22 Jan 2018 Author responded Author comments - Ozlem Aslan
Resubmission - Version 7
22 Jan 2018 Submitted Manuscript version 7
Publishing
23 Jan 2018 Editorially accepted
9 Feb 2018 Article published 10.1186/s12885-018-4035-0

You can find further information about peer review here.

Back to article page
\